Further, various xenograft models, like a pancreatic tumor xenograft [36], a hepatocellular carcinoma xenograft [37], and a melanoma xenograft [38] underlined the relevant role of ERK5 in tumorigenesis since pharmacological inhibition of ERK5 resulted in tumor growth inhibition. The gene discussed is MAPK7; the disease is hepatocellular carcinoma.